Connor Clark & Lunn Investment Management Ltd. Invests $7.67 Million in Cognex Corporation $CGNX

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Cognex Corporation (NASDAQ:CGNXFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 105,970 shares of the scientific and technical instruments company’s stock, valued at approximately $7,674,000. Connor Clark & Lunn Investment Management Ltd. owned 0.06% of Cognex as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Cognex in the second quarter worth about $1,158,123,000. Northwestern Mutual Wealth Management Co. grew its position in Cognex by 173,138.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after purchasing an additional 10,471,400 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Cognex by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock valued at $191,231,000 after acquiring an additional 1,258,629 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its holdings in shares of Cognex by 0.9% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock worth $151,264,000 after purchasing an additional 40,927 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in Cognex by 27.1% in the 4th quarter. Geode Capital Management LLC now owns 3,950,299 shares of the scientific and technical instruments company’s stock worth $142,154,000 after buying an additional 842,783 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Stock Performance

Shares of NASDAQ:CGNX opened at $61.72 on Thursday. The stock’s 50-day simple moving average is $64.60 and its two-hundred day simple moving average is $59.30. The stock has a market capitalization of $10.38 billion, a price-to-earnings ratio of 59.92 and a beta of 1.49. Cognex Corporation has a 52-week low of $34.60 and a 52-week high of $72.88.

Cognex (NASDAQ:CGNXGet Free Report) last released its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same quarter in the prior year, the firm earned $0.25 EPS. The business’s revenue for the quarter was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, equities analysts forecast that Cognex Corporation will post 1.68 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 0.6%. The ex-dividend date is Thursday, August 20th. Cognex’s payout ratio is 33.01%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CGNX. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $75.00 price target on shares of Cognex in a report on Thursday, May 7th. Weiss Ratings raised shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Stephens increased their price objective on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Barclays restated an “overweight” rating and issued a $80.00 target price (up from $75.00) on shares of Cognex in a report on Monday, August 10th. Finally, DA Davidson set a $65.00 target price on shares of Cognex and gave the company a “neutral” rating in a research note on Monday, August 10th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.64.

Get Our Latest Report on Cognex

About Cognex

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Featured Stories

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.